Form 4 • Statement of Changes in Beneficial Ownership
Type
Neutral
Net shares
+996
% of shares
80.65%
Amount (USD)
$0
Insider confidence score
90.0 out of 100
Positive
Negative
Security
Common Stock
Action
Grant
Date
2026-03-02
Code
A
Net shares
+498.0
Price per Share
$35.97
Amount (USD)
$17,913.06
Acquired/Disposed
Acquired
Shares Owned Before
1,235.0
Shares Owned After
1,733.0
Security
Common Stock
Action
Grant
Date
2026-03-02
Code
A
Net shares
+498.0
Acquired/Disposed
Acquired
Shares Owned Before
1,733.0
Shares Owned After
2,231.0
1. The Reporting Person purchased shares ("Purchase Plan Shares") of the Issuer's common stock pursuant to a purchase plan ("Purchase Plan") established under the Corcept Therapeutics Incorporated 2024 Incentive Award Plan on March 2, 2026.
2. In accordance with the Purchase Plan, the price was established based on the closing price on the day of the purchase.
3. Includes 224 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on December 1, 2025. 100% of the shares underlying the restricted stock awards will vest on the one-year anniversary of the grant date provided the Reporting Person satisfies certain requirements.
4. Shares underlie unvested restricted stock awards granted to the Reporting Person by the Issuer under the Purchase Plan. 100% of the shares underlying the restricted stock awards will vest on the one-year anniversary of the grant date provided the Reporting Person remains the beneficial owner of the Purchase Plan Shares through such one-year anniversary.
This page is for informational purposes only. While we strive for accuracy, the summary may contain inaccuracies or omissions. Please refer to the official SEC filing for authoritative information. Open the SEC filing.